Adaptin Bio (APTN) Shares Outstanding (2022 - 2026)

Adaptin Bio's Shares Outstanding history runs 5 years deep, the most recent figure standing at $8.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 4.58% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $8.8 million (up 4.58% YoY), while the FY2025 annual figure was $8.7 million, up 166.46% from the prior year.
• Shares Outstanding came in at $8.8 million for Q1 2026 at Adaptin Bio, up from $8.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $8.8 million in Q1 2026 to a low of $1505.0 in Q4 2024.
• A 5-year average of $5.4 million and a median of $5.0 million in 2022 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding plunged 35.0% in 2023 and surged 166.46% in 2025, its largest moves.
• Adaptin Bio's Shares Outstanding stood at $5.0 million in 2022, then slumped by 35.0% to $3.2 million in 2023, then slipped by 0.05% to $3.2 million in 2024, then soared by 166.46% to $8.7 million in 2025, then gained by 1.51% to $8.8 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $8.8 million, $8.7 million, and $8.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison